1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-119459
    Fluopyram

    氟吡菌酰胺

    Activator 99.76%
    Fluopyram 是一种口服活性琥珀酸脱氢酶 (succinate dehydrogenase) 抑制剂,抗真菌剂 (antifungal) 和杀线虫剂。Fluopyram 抑制琥珀酸脱氢酶的活性、激活 CAR/PXR 核受体、增加 caspase-3TNF-αNF-κB。Fluopyram 抑制 F. virguliformeBotrytis cinereaAlternaria solani 的生长,EC50 值分别为 3.35、5.389 和 0.244 µg/mL。Fluopyram 诱导肝脏、甲状腺肿瘤形成。Fluopyram 具有肾脏、胚胎毒性。
    Fluopyram
  • HY-N0807
    Swertiamarin

    獐牙菜苦苷

    Modulator 99.03%
    Swertiamarin 是一种口服有效的天然产物,具有降血糖、降血脂、抗风湿、抗氧化活性。Swertiamarin 可以调节促炎细胞因子、MMPNF-κB 水平并促进成骨细胞增殖。Swertiamarin 可以通过 Nrf2/HO-1 途径对四氯化碳诱导的大鼠肝毒性具有抗氧化和保肝作用。Swertiamarin 可以通过调节佐剂诱导的关节炎大鼠中的 JAK2/STAT3 转录因子来减弱炎症介质。Swertiamarin 可用于糖尿病、关节炎疾病的研究。
    Swertiamarin
  • HY-N0041
    Ginsenoside Rb3

    人参皂苷 Rb3

    Inhibitor 99.87%
    Ginsenoside Rb3 是从 Panax ginseng C. A. Meyer 中提取的。在 293T 细胞系中 Ginsenoside Rb3 抑制 TNFα 诱导的 NF-κB 转录活性,IC50 为 8.2 μM。Ginsenoside Rb3 还抑制 COX-2iNOS mRNA的诱导。
    Ginsenoside Rb3
  • HY-W082785A
    L6H21 Inhibitor 99.19%
    L6H21 是 Chalcone (HY-121054) 衍生物,是一种口服有效的特异性骨髓分化蛋白 (MD-2) 抑制剂。L6H21 高亲和力地直接与 MD-2 蛋白结合,KD 值为 33.3 μM,阻断 LPS-TLR4/MD-2 复合物形成。L6H21 抑制 LPS 诱导的 RAW264.7 巨噬细胞中 TNF-α IL-6 的表达,IC50 分别为 6.58 和 8.59 μM。L6H21 可用于酒精性肝病、代谢紊乱和神经炎症的研究。
    L6H21
  • HY-101364A
    CHPG sodium salt Activator 99.25%
    CHPG sodium salt 是一个选择性的 mGluR5 激动剂,并且通过 TSG-6/NF-κB 途径减弱 BV2 小神经胶质细胞 SO2 诱导的氧化应激和炎症。 CHPG sodium salt 通过 ERKAkt 途径在体外和体内预防创伤性脑损伤 (TBI)。
    CHPG sodium salt
  • HY-N2543
    Damascenone

    1- (2,6,6-三甲基-1,3-环己二烯-1-基)-2-丁烯-1-酮

    Inhibitor 99.26%
    Damascenone ((E/Z)-Damascenone) 源于 Epipremnum pinnatum 的具有抗炎活性的活性化合物。Damascenone 是E- 和Z- 异构体大马士革酮的混合物。
    Damascenone
  • HY-B0130A
    Perindopril erbumine

    培哚普利叔丁胺

    99.98%
    Perindopril erbumine 是一种血管紧张素转换酶 (angiotensin-converting enzyme) 抑制剂,调节 NF-κBSTAT3 信号传导,抑制胶质细胞活化和神经炎症,可用于慢性肾脏病和高血压的研究。
    Perindopril erbumine
  • HY-Y1267D
    Magnesium sulfate, for cell culture

    硫酸镁, 用于细胞培养

    Inhibitor 99.0%
    Magnesium sulfate, for cell culture 适用于细胞培养。Magnesium sulfate 是一种钙拮抗剂和有效的 L 型钙通道抑制剂,也是一种宫缩抑制剂。Magnesium sulfate 具有抗炎、抗惊厥、血管舒张和神经保护的作用。Magnesium sulfate 可用于先兆子痫/子痫等疾病的研究。
    Magnesium sulfate, for cell culture
  • HY-14654S
    Aspirin-d3

    阿司匹林 d3

    Inhibitor 98.51%
    Aspirin-d3 是 Aspirin (HY-14654) 的氘代物。Aspirin (Acetylsalicylic acid) 是一种口服有效的不可逆的环氧合酶 COX-1COX-2 抑制剂,IC50 分别为 5 和 210 μg/mL. Aspirin 诱导细胞凋亡 (apoptosis)。Aspirin 可抑制 NF-κB 的活化。Aspirin 还抑制血小板前列腺素合成酶 (prostaglandin synthetase),可预防冠状动脉和脑血管血栓形成。
    Aspirin-d<sub>3</sub>
  • HY-153368
    Zomiradomide Inhibitor
    Zomiradomide 是一种口服有效的 PROTAC 降解剂,可降解IRAK4DC50=6 nM),从而抑制 NF-κB 信号通路。Zomiradomide 还可作为分子胶,募集 Ikaros 和 Aiolos 并介导其降解(Ikaros 的DC50为1 nM),从而激活 I 型干扰素信号通路。(Pink: target protein ligand PROTAC IRAK4 ligand-5 (HY-168311), Blue: E3 ligase ligand Thalidomide-4-Br (HY-W039116), Black: linker (HY-168313))
    Zomiradomide
  • HY-N6051
    (-​)​-Maackiain

    高丽槐素

    Inhibitor 99.91%
    (-)-Maackiain 是由Sophora flavescens 产生的紫檀素类植物抗毒素。(-)-Maackiain 对豆科植物和非豆科植物宿主的几种真菌病原体有毒。(-)-Maackiain 可增强 NLRP3 炎症小体的活化,抑制 NF-κB 通路的活化,从而发挥免疫刺激和抗炎活性。(-)-Maackiain 具有口服活性。
    (-​)​-Maackiain
  • HY-P1832A
    PTD-p65-P1 Peptide TFA Inhibitor 99.14%
    PTD-p65-P1 Peptide TFA 是一种有效的选择性核转录因子 NF-κB 抑制剂,来源于 NF-κB 氨基酸残基 271-282 的 p65 亚单位,可选择性抑制各种炎症刺激诱导的 NF-κB 激活,下调 NF-κB 介导的基因表达,并上调细胞凋亡(apoptosis)。
    PTD-p65-P1 Peptide TFA
  • HY-N2450
    Sulforaphene Inhibitor 99.80%
    Sulforaphene 可从萝卜籽中提取得到,对绒毛叶种子的ED50 值为2 x 10-4 M。Sulforaphene 促进癌细胞的凋亡,通过下调EGFRp-ERK1/2NF‐κB 等抑制癌细胞迁移。
    Sulforaphene
  • HY-16561A
    cis-Resveratrol

    顺式白藜芦醇

    Inhibitor 98.84%
    cis-Resveratrol 具有显着的抗病毒活性。cis-Resveratrol 抑制肠道病毒,对 CVB3 和 EV71 的 IC50 分别为 12.2 µM 和 37.6 µM。cis-Resveratrol 是 NF-κB 信号通路的抑制剂。
    cis-Resveratrol
  • HY-N0648
    Monotropein Inhibitor 99.09%
    Monotropein 是一种环烯醚萜苷,可从巴戟天根中分离得到。Monotropein 可抑制葡聚糖硫酸钠 (DSS) 诱发的结肠炎小鼠模型中炎症介质的表达。Monotropein 对 IL-1β 诱导的骨关节炎软骨细胞凋亡 (apoptosis) 和分解代谢反应具有保护作用。Monotropein 具有软骨保护活性。Monotropein 可通过激活 Nrf2/HO-1 通路和抑制 NF-κB 信号传导来抑制氧化损伤、炎症和细胞凋亡,从而减轻顺铂 (HY-17394) 诱导的急性肾损伤。Monotropein 可用于骨关节炎、急性肾损伤和急性肺损伤的研究。
    Monotropein
  • HY-121705
    Propionyl-L-carnitine Inhibitor
    Propionyl-L-carnitine 是一种口服活性的 L-carnitine 衍生物。Propionyl-L-carnitine 对肌肉L-肉碱转移酶具有高亲和力。Propionyl-L-carnitine 可增加凋亡 (Apoptosis)、Bax,并降低 NF-κBVCAM-1MCP-1survivin。Propionyl-L-carnitine 可激活 Src 激酶、Akt,诱导 p-AMPK 和一氧化氮合成 (nitric oxide synthesis)。Propionyl-L-carnitine 可缓解心血管疾病、肥胖症和结肠炎。
    Propionyl-L-carnitine
  • HY-N0747
    Oxypeucedanin

    氧化前胡素

    Inhibitor 99.50%
    Oxypeucedanin 是可在 Angelica dahurica 中发现的呋喃香豆素衍生物。Oxypeucedanin 是一种具有口服活性的 PI3K/AKT/NF-κBMAPKROS 抑制剂。Oxypeucedanin 可诱导细胞周期阻滞和细胞凋亡 (apoptosis)。Oxypeucedanin 可抑制 hKv1.5 通道电流 (IC50: 76 nM)。Oxypeucedanin 具有抗癌、抗炎、抗氧化和抗心律失常活性。
    Oxypeucedanin
  • HY-B0612
    Lercanidipine

    乐卡地平

    Inhibitor 99.65%
    Lercanidipine 是第三代、亲脂性、可穿透血脑屏障、血管选择性、具有口服活性的二氢吡啶钙通道阻断剂,pIC50 为 7.74(由 微摩尔浓度 转换而来)。Lercanidipine 具有持久的降压作用以及肾脏和神经保护作用,还具有抗氧化、抗炎和抗凋亡的特性。Lercanidipine 可用于心血管和神经学研究。
    Lercanidipine
  • HY-P9958A
    Denosumab (anti-TNFSF11) Inhibitor 99.9%
    Denosumab (anti-TNFSF11) 是一种靶向 RANKL 蛋白的人单克隆抗体。Denosumab 结合 receptor activator of nuclear factor kappa-B ligand (RANKL) 并阻止其与 RANK 受体结合 (对人 RANKL 的 KD 为 0.003 nM)。Denosumab 促进增殖和精子发生。Denosumab 通过抑制 NF-κB 途径防止骨吸收。Denosumab 可用于骨相关研究。
    Denosumab (anti-TNFSF11)
  • HY-P1847A
    IKKγ NBD Inhibitory Peptide TFA 98.20%
    IKKγ NBD 抑制肽 TFA 是一种高度特异性的 NF-κB 抑制剂。IKKγ NBD 抑制肽 TFA 通过阻断 IKKγ/NEMO 结合域 (NBD) 与 IKKα 和 IKKβ 之间的相互作用,而阻断 TNF-α 诱导的 NF-κB 激活。IKKγ NBD 抑制肽 TFA 可显著降低炎症、改善脑缺血所致的神经功能缺损。
    IKKγ NBD Inhibitory Peptide TFA
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.